Home
Live
News
Create
Screeners
Insights
Syschem
55.
00
+0.20
(+0.36%)
Market Cap
₹238.40 Cr
PE Ratio
119.28
Industry
Healthcare
Buy
Sell
Company Performance:
1D
+0.36%
1M
+0.95%
6M
+30.58%
1Y
+37.05%
5Y
+809.09%
View Company Insights
Latest news about Syschem
Syschem (India) Unveils Ambitious Expansion Plan for Antibiotic Production
Sep 29, 2025
Syschem (India) Limited announces significant expansion of its antibiotic production capabilities. The company's board has approved plans for a new factory to produce Cloxacillin, Dicloxacillin, and Flucloxacillin Sodium, as well as the expansion of its existing amoxicillin unit. The total investment is estimated at Rs. 15.00 to 20.00 Crore, financed through internal accruals or debt funding. The expansion will add 1,600.00 TPA to the current plant capacity of 2,400.00 TPA. The project is expected to be completed by December 2025, aiming to improve operational efficiency, strengthen product portfolio, and meet growing customer demand.
Syschem (India) Limited Wins Litigation Case, Faces Rs 15.00 Lakh Financial Impact
Sep 12, 2025
Syschem India Reports 24% Revenue Growth in Q1, Expands Production Capacity
Aug 04, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation